2m 2m 2m 2m 2m 2m 2m
ANIXA BIOSCINCS (ANIX)
NASDAQ
$2.98+$0.20 (+7.19%)
Price as of Oct 23, 2026 7:30 PM EDT- $96.6MMarket Cap
- -33.49%1-Year Change
- BiotechnologyIndustry
ANIXA BIOSCINCS (ANIX)
$2.98+$0.20 (+7.19%)
ANIX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.78 | ||
Change | +$0.07 (+2.58%) | ||
Open | $2.70 | ||
High | $2.78 | ||
Low | $2.68 | ||
Previous Close | $2.71 | ||
Volume | 156,811 | ||
30-Day Average Volume | 256,763 | ||
1-Week Change | 0.00% | ||
1-Month Change | -0.36% | ||
1-Year Change | -33.49% | ||
3-Year Change | -11.18% | ||
5-Year Change | -35.94% | ||
Fundamentals | |||
Shares Outstanding | 34.8M | ||
Total Assets | $15.1M | ||
Market Cap | $96.6M | ||
Enterprise Value | $95.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$2.6M | ||
Free Cash Flow | -$1.8M | ||
EBIT | -$2.6M | ||
EBITDA | -$2.6M | ||
Net Working Capital | $13.2M | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | -37 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -35 | ||
PEG | 2 | ||
Price/Free Cash Flow | -55 | ||
Price/Operating Cash Flow | -55 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue